| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10308604 | Seizure | 2005 | 5 Pages |
Abstract
The results of our pilot study suggested that anti-GM1 and anti-GAD antibodies are rare and they did not associate with therapy-resistance and other parameters in JME syndrome.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Ebru Aykutlu, Betül Baykan, Candan Gürses, AyÅen Gokyigit, Güher Saruhan-Direskeneli,